3D Bioprinted Human Tissue Market Research Report Information By Technology (Magnetic Levitation Bioprinting, Inkjet Bioprinting, Syringe/Extrusion Bioprinting, and Laser-Assisted Bioprinting), By Application (Drug Testing and Development, Regenerative Medicine, Clinical Application, Food Testing, and Research), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY

6.1. Overview

6.2. Magnetic Levitation Bioprinting

6.3. Inkjet Bioprinting

6.4. Syringe/Extrusion Bioprinting

6.5. Laser-Assisted Bioprinting

7. GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION

7.1. Overview

7.2. Drug Testing and Development

7.3. Regenerative Medicine

7.4. Clinical Application

7.5. Food Testing

7.6. Research

8. GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global 3D Bioprinted Human Tissue Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global 3D Bioprinted Human Tissue Market,

9.7. Key Developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2023

9.8.2. Major Players R&D Expenditure. 2023

10. COMPANY PROFILES

10.1. 3D Bioprinting Solutions

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. ALLEVI

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Cellink Global

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Cyfuse Biomedical K.K.

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. EnvisionTEC, Inc

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. INVENTIA LIFE SCIENCE PTY LTD

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Organovo Holdings, Inc

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. POIETIS

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Regemat 3D S.L

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. VIVAX BIO, LLC

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 7 US: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 8 US: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 9 CANADA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 10 CANADA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 11 EUROPE: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 12 EUROPE: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 13 GERMANY: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 14 GERMANY: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 15 FRANCE: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 16 FRANCE: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 17 ITALY: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 18 ITALY: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 19 SPAIN: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 20 SPAIN: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 21 UK: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 22 UK: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 23 REST OF EUROPE: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 24 REST OF EUROPE: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 25 ASIA-PACIFIC: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 26 ASIA-PACIFIC: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 28 JAPAN: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 29 CHINA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 30 CHINA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 31 INDIA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 32 INDIA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 33 AUSTRALIA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 35 SOUTH KOREA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 36 SOUTH KOREA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 37 REST OF ASIA-PACIFIC: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 38 REST OF ASIA-PACIFIC: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 39 REST OF THE WORLD: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 40 REST OF THE WORLD: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 41 MIDDLE EAST: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 42 MIDDLE EAST: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 43 AFRICA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 44 AFRICA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 45 LATIN AMERICA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 46 LATIN AMERICA: 3D BIOPRINTED HUMAN TISSUE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET

FIGURE 4 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY TECHNOLOGY, 2023

FIGURE 5 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 6 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY REGION, 2023

FIGURE 7 NORTH AMERICA: 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 EUROPE: 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 ASIA-PACIFIC: 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 REST OF THE WORLD: 3D BIOPRINTED HUMAN TISSUE MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 GLOBAL 3D BIOPRINTED HUMAN TISSUE MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 12 3D BIOPRINTING SOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 3D BIOPRINTING SOLUTIONS: SWOT ANALYSIS

FIGURE 14 ALLEVI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ALLEVI: SWOT ANALYSIS

FIGURE 16 CELLINK GLOBAL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 CELLINK GLOBAL: SWOT ANALYSIS

FIGURE 18 CYFUSE BIOMEDICAL K.K: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 CYFUSE BIOMEDICAL K.K: SWOT ANALYSIS

FIGURE 20 ENVISIONTEC, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 ENVISIONTEC, INC: SWOT ANALYSIS

FIGURE 22 INVENTIA LIFE SCIENCE PTY LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 INVENTIA LIFE SCIENCE PTY LTD: SWOT ANALYSIS

FIGURE 24 ORGANOVO HOLDINGS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 ORGANOVO HOLDINGS, INC.: SWOT ANALYSIS

FIGURE 26 POIETIS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 POIETIS: SWOT ANALYSIS

FIGURE 28 REGEMAT 3D S.L: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 REGEMAT 3D S.L: SWOT ANALYSIS

FIGURE 30 VIVAX BIO, LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 VIVAX BIO, LLC: SWOT ANALYSIS